1/27
A comprehensive set of vocabulary flashcards covering the definition, classification, risk factors, diagnostic tools, imaging, and management of ischaemic stroke based on BMJ Best Practice guidelines.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
World Health Organization Definition of Stroke
A clinical syndrome consisting of rapidly developing clinical signs of focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin.
Ischaemic Stroke
Stroke caused by vascular occlusion or stenosis that critically reduces cerebral blood flow.
Haemorrhagic Stroke
Stroke caused by vascular rupture, resulting in intraparenchymal and/or subarachnoid haemorrhage.
Central Venous Sinus Thrombosis
A rare form of stroke that occurs due to thrombosis of the dural venous sinuses.
ROSIER Scale
Recognition of Stroke in the Emergency Room; a validated tool used in the emergency department to aid in the rapid diagnosis of stroke.
FAST
Face Arm Speech Test; a validated screening tool used in the community to identify sudden onset neurological symptoms of stroke.
National Institutes of Health Stroke Scale (NIHSS)
A tool that measures the degree of neurological deficit, where higher scores indicate a more severe stroke.
Trial of Org 10172 in Acute Stroke Treatment (TOAST)
A classification scheme that categorizes ischaemic stroke by pathophysiological mechanisms: large artery atherosclerosis, small vessel occlusion, cardioembolism, other determined aetiology, and indeterminate aetiology.
Large Artery Atherosclerosis
Infarction in the perfusion territory of an extracranial or intracranial artery with >50% stenosis, where thrombus formation embolises to distal sites.
Small Vessel (Lacunar) Stroke
A stroke caused by thrombotic occlusion of a small penetrating artery affected by lipohyalinosis, resulting in an infarct <1.5cm in diameter.
Lipohyalinosis
Lipid accumulation due to ageing and hypertension that affects small penetrating arteries.
Cardioembolism
Stroke resulting from thrombus formation in the heart, such as from atrial fibrillation, which then embolises to the intracranial circulation.
Bamford (Oxford) Classification
A system that classifies ischaemic stroke based on initial presenting symptoms and clinical signs (Total Anterior, Partial Anterior, Posterior, and Lacunar) without requiring imaging.
Amaurosis Fugax
Transient monocular vision loss that serves as a common early warning signal for cervical carotid stenosis.
Horner's Syndrome
A hemilateral triad consisting of miosis, ptosis, and facial anhidrosis, which may be associated with posterior circulation strokes or carotid artery dissection.
Todd’s Paresis
Postictal focal neurological deficits, such as hemiparesis, following a seizure that can mimic a stroke.
Alteplase
A recombinant tissue plasminogen activator used for intravenous thrombolysis, best initiated within 4.5hours of symptom onset.
Tenecteplase
An alternative thrombolytic agent considered safe and effective to alteplase within 4.5hours of ischaemic stroke, but not recommended for wake-up strokes without specialized imaging.
Mechanical Thrombectomy
An endovascular procedure to retrieve a clot, performed in selected patients with proximal large vessel occlusion within 6 to 24hours of symptom onset.
DWI-FLAIR Mismatch
A state where an ischaemic lesion is visible on diffusion-weighted MRI but not on fluid-attenuated inversion recovery MRI, indicating the stroke likely occurred within the previous 4.5hours.
Decompressive Hemicraniectomy
The neurosurgical removal of part of the skull to reduce intracranial pressure, considered for patients with large middle cerebral artery territory infarcts within 48hours of onset.
Secondary Prevention Glucose Target
Maintenance of blood glucose concentration between 4mmol/L and 11mmol/L.
Ischaemic Stroke Blood Pressure Threshold (Thrombolysis)
Blood pressure should be reduced to 185/110mmHg or lower specifically for patients who are candidates for intravenous thrombolysis.
Atrial Fibrillation (AF)
A cardiac arrhythmia causing at least one fifth of ischaemic strokes and requiring anticoagulation (usually with a DOAC) for secondary prevention.
Moyamoya Disease
Vascular occlusion affecting the circle of Willis, associated with sickle cell disease.
Wernicke's Encephalopathy
A stroke mimic presenting with irritability, confusion, and delirium, associated with alcohol abuse and decreased blood thiamine levels.
ASPECTS
Alberta Stroke Program Early Computed Tomography Score; used to determine eligibility for mechanical thrombectomy between 6 and 24hours.
Dual Antiplatelet Therapy (DAPT)
The combination of aspirin with clopidogrel (for 21days) or aspirin with ticagrelor (for 30days) used for minor ischaemic stroke (NIHSS≤3).